165 related articles for article (PubMed ID: 31764519)
21. Age related changes in brain MR appearance in the course of neurocutaneous melanosis.
Bekiesińska-Figatowska M; Sawicka E; Żak K; Szczygielski O
Eur J Radiol; 2016 Aug; 85(8):1427-31. PubMed ID: 27423683
[TBL] [Abstract][Full Text] [Related]
22. Neurocutaneous melanosis presenting with hydrocephalus. Case report and review of the literature.
Acosta FL; Binder DK; Barkovich AJ; Frieden IJ; Gupta N
J Neurosurg; 2005 Jan; 102(1 Suppl):96-100. PubMed ID: 16206742
[TBL] [Abstract][Full Text] [Related]
23. Malignant transformation of neurocutaneous melanosis (NCM) following immunosuppression.
Schaff LR; Marghoob A; Rosenblum MK; Meyer R; Khakoo Y
Pediatr Dermatol; 2019 Jul; 36(4):497-500. PubMed ID: 30868657
[TBL] [Abstract][Full Text] [Related]
24. Neurocutaneous melanosis with hydrocephalus: report of one case.
Hsueh CW; Ho CS; Chiu NC; Shen EY
Acta Neurol Taiwan; 2004 Mar; 13(1):29-33. PubMed ID: 15315299
[TBL] [Abstract][Full Text] [Related]
25. Large congenital melanocytic nevi and the risk for development of malignant melanoma and neurocutaneous melanocytosis.
Bittencourt FV; Marghoob AA; Kopf AW; Koenig KL; Bart RS
Pediatrics; 2000 Oct; 106(4):736-41. PubMed ID: 11015516
[TBL] [Abstract][Full Text] [Related]
26. Leptomeningeal melanocytosis in an adult male without large congenital nevi: a rare and atypical case of neurocutaneous melanosis.
Sutton BJ; Tatter SB; Stanton CA; Mott RT
Clin Neuropathol; 2011; 30(4):178-82. PubMed ID: 21726502
[TBL] [Abstract][Full Text] [Related]
27. Metastatic peritoneal neurocutaneous melanocytosis.
Cajaiba MM; Benjamin D; Halaban R; Reyes-Múgica M
Am J Surg Pathol; 2008 Jan; 32(1):156-61. PubMed ID: 18162783
[TBL] [Abstract][Full Text] [Related]
28. Neurocutaneous melanosis in children with giant congenital melanocytic nevi.
Bekiesinska-Figatowska M; Szczygielski O; Boczar M; Madzik J; Klepacka T; Michalak E; Romaniuk-Doroszewska A; Uliasz M; Peczkowski P; Sawicka E
Clin Imaging; 2014; 38(2):79-84. PubMed ID: 24239041
[TBL] [Abstract][Full Text] [Related]
29. Neurocutaneous melanocytosis-associated malignant melanoma presenting with peritoneal seeding.
Sener U; Elmore K; Jayaseelan K; Porter J; Marghoob A; Rosenblum MK; Haque S; Khakoo Y
Pediatr Dermatol; 2021 Sep; 38(5):1298-1301. PubMed ID: 34463389
[TBL] [Abstract][Full Text] [Related]
30. Neurocutaneous melanosis associated with malignant leptomeningeal melanoma in an adult: clinical significance of 5-S-cysteinyldopa in the cerebrospinal fluid---case report.
Shinno K; Nagahiro S; Uno M; Kannuki S; Nakaiso M; Sano N; Horiguchi H
Neurol Med Chir (Tokyo); 2003 Dec; 43(12):619-25. PubMed ID: 14723271
[TBL] [Abstract][Full Text] [Related]
31. Nevospheres from neurocutaneous melanocytosis cells show reduced viability when treated with specific inhibitors of NRAS signaling pathway.
Basu D; Salgado CM; Bauer BS; Johnson D; Rundell V; Nikiforova M; Khakoo Y; Gunwaldt LJ; Panigrahy A; Reyes-Múgica M
Neuro Oncol; 2016 Apr; 18(4):528-37. PubMed ID: 26354928
[TBL] [Abstract][Full Text] [Related]
32. Clinical Follow-Up of Patients with Neurocutaneous Melanosis in a Tertiary Center; Proposed Modification in Diagnostic Criteria.
Habibi Z; Ebrahimi H; Meybodi KT; Yaghmaei B; Nejat F
World Neurosurg; 2021 Feb; 146():e1063-e1070. PubMed ID: 33246180
[TBL] [Abstract][Full Text] [Related]
33. Large congenital melanocytic nevi and neurocutaneous melanocytosis: one pediatric center's experience.
Lovett A; Maari C; Decarie JC; Marcoux D; McCuaig C; Hatami A; Savard P; Powell J
J Am Acad Dermatol; 2009 Nov; 61(5):766-74. PubMed ID: 19766348
[TBL] [Abstract][Full Text] [Related]
34. Neurocutaneous melanosis.
Makkar HS; Frieden IJ
Semin Cutan Med Surg; 2004 Jun; 23(2):138-44. PubMed ID: 15295923
[TBL] [Abstract][Full Text] [Related]
35. Primary temporal melanoma without diffuse leptomeningeal involvement: a variant of neurocutaneous melanosis.
Eaves FF; Burstein FD; Hudgins R; Cohen SR; Papciack M
Plast Reconstr Surg; 1995 Jan; 95(1):133-5. PubMed ID: 7809226
[TBL] [Abstract][Full Text] [Related]
36. Large congenital melanotic nevi in an extremity with neurocutaneous melanocytosis.
Becher OJ; Souweidane M; Lavi E; Kramer K; Lis E; Marghoob AA; Khakoo Y
Pediatr Dermatol; 2009; 26(1):79-82. PubMed ID: 19250413
[TBL] [Abstract][Full Text] [Related]
37. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi.
Salgado CM; Basu D; Nikiforova M; Bauer BS; Johnson D; Rundell V; Grunwaldt LJ; Reyes-Múgica M
Pediatr Dev Pathol; 2015; 18(1):1-9. PubMed ID: 25490715
[TBL] [Abstract][Full Text] [Related]
38. Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi--results from the NYU-LCMN registry.
Hale EK; Stein J; Ben-Porat L; Panageas KS; Eichenbaum MS; Marghoob AA; Osman I; Kopf AW; Polsky D
Br J Dermatol; 2005 Mar; 152(3):512-7. PubMed ID: 15787820
[TBL] [Abstract][Full Text] [Related]
39. Neurocutaneous melanosis with leptomeningeal melanoma.
Akinwunmi J; Sgouros S; Moss C; Grundy R; Green S
Pediatr Neurosurg; 2001 Nov; 35(5):277-9. PubMed ID: 11741125
[No Abstract] [Full Text] [Related]
40. Making a mountain out of a molehill: NRAS, mosaicism, and large congenital nevi.
Gerami P; Paller AS
J Invest Dermatol; 2013 Sep; 133(9):2127-30. PubMed ID: 23949765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
